Application of indirubin in preparing medicine for treating influenza virus infection

Abstract

The invention discloses an application of indirubin in preparing a medicine for treating or preventing influenza virus infection. People find that the indirubin has good inhibiting effect on influenza viruses but basically has no toxicity to cells by measuring the inhibiting action of the indirubin on the cell toxicity and the influenza viruses. Therefore, the indirubin can be further developed as the medicine for treating diseases caused by influenza virus infection, and has wide application prospects.

Description

technical field [0001] The invention belongs to the field of biomedicine, and more specifically relates to an application of indirubin in the preparation of medicines for treating or preventing influenza virus infection. Background technique [0002] Influenza virus (IV) can cause acute respiratory infectious diseases in humans and animals, can spread through the air, is highly contagious, and is very prone to epidemics. Can cause myocarditis, pneumonia, bronchitis and other complications. Influenza virus belongs to the family Orthomyxoviridae, its genome is segmented RNA, and the virus particle is spherical, and its structure can be divided into three parts: envelope, matrix protein and core from outside to inside. According to the difference in antigenicity of viral nucleoprotein (NP) and matrix protein, it can be divided into three types: A (A), B (B) and C (C); The antigenicity of the enzyme (NA) divides it into different subtypes. According to the historical data of ...

AI Technical Summary

Problems solved by technology

At the same time, due to the difference in individual immunity, the vaccine only has a preventive effect on known influenza virus subtypes, but is ineffective against new influenza viruses produced by antigenic drift or antigenic drift.

Images